The total value of Acacia’s investment in Oxford Nanopore both realised and unrealised now stands at $297.5m, which is larger than the approximately £220m the firm paid Link Fund Solutions for a 19-asset life sciences portfolio in December 2020.
Oxford Nanopore's September IPO added almost $120m to the value of Acacia Research's life sciences portfolio, which the firm acquired from the former Woodford Equity Income fund. Acacia chief executive Clifford Press described the results as a "milestone quarter highlighted by the IPO of Oxford Nanopore", which represented a nearly $120m "realised and unrealised gain". Link completes Woodford-Acacia deal as LF Equity Income value reduces after Ombu deal The results revealed the firm had sold 3.9m shares during Q3 and retains a 35.1m share stake in the firm, which has increased in v...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
